Glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus-Practical implications

Diabetes Research and Clinical Practice

Volumn 93, Issue 3, 2011, Pages 312-313

  Colagiuri, Stephen ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ALGORITHM; BLOOD GLUCOSE MONITORING; CLINICAL PROTOCOL; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIET RESTRICTION; HEALTH CARE COST; HEALTH CARE SYSTEM; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBINOPATHY; HUMAN; NOTE; ORAL GLUCOSE TOLERANCE TEST; PRACTICE GUIDELINE; PREVALENCE; QUALITY CONTROL; REFERENCE VALUE; STANDARDIZATION;

DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS;

EID: 80052738101     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.06.025     Document Type: Note

References (5)

1. World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 2011;93:299-9.
2. Report of a WHO/IDF consultation Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia 2006, WHO, Geneva.
3. Colagiuri S. Mismatch between diagnosis in primary care and recommended diagnostic criteria. Diabetes Res Clin Pract 2011, 91:263-264.
4. 2010 Consensus statement on the worldwide standardization of the hemoglobin A1c measurement. Diabetes Res Clin Pract 2010;90:228-30.
5. Kowall B., Rathmann W., Landgraf R. Is HbA1c a valid and feasible tool for the diagnosis of diabetes?. Diabetes Res Clin Pract 2011, 93:314-316.